Kidney Disease Poc Analyzer

Ideal for the treatment of hypertension, diabetes, and as a potential indicator of preeclampsia during pregnancy, microalbuminuria is screened and monitored.The HemoCue Albumin 201 System is a simple, laboratory-accurate method for detecting microalbuminuria, long before any potential symptoms of renal or vascular complications may manifest. Quantitative test results are obtained at the point of care through HemoCue’s patented microcuvette technology. You have the ability to provide the patient with direct feedback and make immediate treatment decisions.input:
output:
Confidence in critical decisionsinput:
output:
Results that are precise in the laboratory for the purposes of screening, diagnosis, and monitoring

Capacity to monitor fluctuations in albumin concentration within the extremely low range of 5-20 mg/L

Detection of low concentrations allows for early treatment, which can delay the onset of future microvascular complications.With ease, rapid results are achieved.Ease of use with minimal training – Three straightforward steps

Results of the test are available in a mere 90 seconds.There is no requirement for laboratory confirmation as a result of the quantitative results.Acknowledged and dependable methodologyinput:
output:Based on the reputable microcuvette technology of HemoCueA system that is factory calibrated guarantees sustainable and dependable outcomes.